Guangzhou Jet Bio-Filtration Co Ltd (688026) - Net Assets
Based on the latest financial reports, Guangzhou Jet Bio-Filtration Co Ltd (688026) has net assets worth CN¥1.20 Billion CNY (≈ $176.01 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.72 Billion ≈ $251.16 Million USD) and total liabilities (CN¥513.57 Million ≈ $75.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See 688026 net asset quality index to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.20 Billion |
| % of Total Assets | 70.08% |
| Annual Growth Rate | 25.27% |
| 5-Year Change | 26.07% |
| 10-Year Change | 741.08% |
| Growth Volatility | 33.25 |
Guangzhou Jet Bio-Filtration Co Ltd - Net Assets Trend (2013–2025)
This chart illustrates how Guangzhou Jet Bio-Filtration Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 688026 stock market capitalisation.
Annual Net Assets for Guangzhou Jet Bio-Filtration Co Ltd (2013–2025)
The table below shows the annual net assets of Guangzhou Jet Bio-Filtration Co Ltd from 2013 to 2025. Also explore Guangzhou Jet Bio-Filtration Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.23 Billion ≈ $179.28 Million |
+2.35% |
| 2024-12-31 | CN¥1.20 Billion ≈ $175.16 Million |
+3.41% |
| 2023-12-31 | CN¥1.16 Billion ≈ $169.39 Million |
+1.53% |
| 2022-12-31 | CN¥1.14 Billion ≈ $166.84 Million |
+17.32% |
| 2021-12-31 | CN¥971.82 Million ≈ $142.21 Million |
+21.95% |
| 2020-12-31 | CN¥796.89 Million ≈ $116.61 Million |
+128.92% |
| 2019-12-31 | CN¥348.11 Million ≈ $50.94 Million |
+23.46% |
| 2018-12-31 | CN¥281.96 Million ≈ $41.26 Million |
+51.76% |
| 2017-12-31 | CN¥185.79 Million ≈ $27.19 Million |
+27.55% |
| 2016-12-31 | CN¥145.66 Million ≈ $21.32 Million |
+21.95% |
| 2015-12-31 | CN¥119.45 Million ≈ $17.48 Million |
+32.45% |
| 2014-12-31 | CN¥90.19 Million ≈ $13.20 Million |
+9.93% |
| 2013-12-31 | CN¥82.04 Million ≈ $12.00 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Guangzhou Jet Bio-Filtration Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1236.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥511.32 Million | 42.04% |
| Other Components | CN¥704.98 Million | 57.96% |
| Total Equity | CN¥1.22 Billion | 100.00% |
Guangzhou Jet Bio-Filtration Co Ltd Competitors by Market Cap
The table below lists competitors of Guangzhou Jet Bio-Filtration Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lao Feng Xiang Co Ltd B
SHG:900905
|
$555.19 Million |
|
Zhejiang Starry Pharm Co Ltd
SHG:603520
|
$555.57 Million |
|
TPG RE Finance Trust Inc
NYSE:TRTX
|
$555.85 Million |
|
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd
SHE:300384
|
$555.97 Million |
|
Ashapura Minechem Limited
NSE:ASHAPURMIN
|
$555.12 Million |
|
Ichitan Group Public Company Limited
BK:ICHI
|
$555.12 Million |
|
ZYF Lopsking Aluminum Co Ltd
SHE:002333
|
$555.05 Million |
|
Nanjing Well Pharmaceutical Co Ltd
SHG:603351
|
$554.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guangzhou Jet Bio-Filtration Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,189,780,067 to 1,216,301,466, a change of 26,521,399 (2.2%).
- Net income of 48,212,800 contributed positively to equity growth.
- Dividend payments of 14,447,348 reduced retained earnings.
- Other comprehensive income decreased equity by 200,086,423.
- Other factors increased equity by 192,842,371.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥48.21 Million | +3.96% |
| Dividends Paid | CN¥14.45 Million | -1.19% |
| Other Comprehensive Income | CN¥-200.09 Million | -16.45% |
| Other Changes | CN¥192.84 Million | +15.85% |
| Total Change | CN¥- | 2.23% |
Book Value vs Market Value Analysis
This analysis compares Guangzhou Jet Bio-Filtration Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.06x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 13.43x to 3.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥2.01 | CN¥27.03 | x |
| 2014-12-31 | CN¥1.58 | CN¥27.03 | x |
| 2015-12-31 | CN¥2.81 | CN¥27.03 | x |
| 2016-12-31 | CN¥3.42 | CN¥27.03 | x |
| 2017-12-31 | CN¥1.91 | CN¥27.03 | x |
| 2018-12-31 | CN¥2.86 | CN¥27.03 | x |
| 2019-12-31 | CN¥2.49 | CN¥27.03 | x |
| 2020-12-31 | CN¥5.69 | CN¥27.03 | x |
| 2021-12-31 | CN¥6.94 | CN¥27.03 | x |
| 2022-12-31 | CN¥8.12 | CN¥27.03 | x |
| 2023-12-31 | CN¥8.31 | CN¥27.03 | x |
| 2024-12-31 | CN¥8.57 | CN¥27.03 | x |
| 2025-12-31 | CN¥8.83 | CN¥27.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guangzhou Jet Bio-Filtration Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.96%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.53%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.43x
- Recent ROE (3.96%) is below the historical average (12.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 16.52% | 19.36% | 0.56x | 1.52x | CN¥5.35 Million |
| 2014 | 9.04% | 9.23% | 0.56x | 1.76x | CN¥-869.20K |
| 2015 | 11.25% | 13.07% | 0.55x | 1.56x | CN¥1.49 Million |
| 2016 | 17.91% | 21.02% | 0.62x | 1.38x | CN¥11.52 Million |
| 2017 | 21.71% | 24.16% | 0.73x | 1.24x | CN¥21.76 Million |
| 2018 | 18.74% | 25.47% | 0.63x | 1.16x | CN¥24.64 Million |
| 2019 | 19.00% | 26.73% | 0.62x | 1.14x | CN¥31.34 Million |
| 2020 | 14.98% | 23.69% | 0.52x | 1.22x | CN¥39.68 Million |
| 2021 | 17.61% | 20.00% | 0.72x | 1.21x | CN¥73.98 Million |
| 2022 | 7.70% | 14.38% | 0.38x | 1.41x | CN¥-26.23 Million |
| 2023 | 3.01% | 7.51% | 0.28x | 1.41x | CN¥-80.91 Million |
| 2024 | 6.07% | 12.92% | 0.33x | 1.43x | CN¥-46.79 Million |
| 2025 | 3.96% | 8.53% | 0.32x | 1.43x | CN¥-73.42 Million |
Industry Comparison
This section compares Guangzhou Jet Bio-Filtration Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,290,495,654
- Average return on equity (ROE) among peers: 2.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guangzhou Jet Bio-Filtration Co Ltd (688026) | CN¥1.20 Billion | 16.52% | 0.43x | $555.19 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.67 Billion | -1.81% | 1.12x | $516.87 Million |
| Blue Sail Medical Co Ltd (002382) | $1.30 Billion | 13.93% | 0.22x | $878.76 Million |
| Andon Health Co Ltd (002432) | $779.96 Million | 3.04% | 0.05x | $4.39 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.21 Billion | 3.44% | 0.58x | $799.71 Million |
| Guangzhou Improve Med Instrument (300030) | $930.46 Million | 4.28% | 0.55x | $313.09 Million |
| QITIAN Technology Group Co Ltd (300061) | $783.38 Million | -63.24% | 1.08x | $684.66 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $1.77 Billion |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $968.97 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $978.79 Million | 15.93% | 0.44x | $695.98 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $520.95 Million | 10.42% | 0.38x | $1.34 Billion |
About Guangzhou Jet Bio-Filtration Co Ltd
Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration products, molecular biology, cellsafe, medical consumables, biological reagents, laboratory equipment, petri dishes, ELISA plates, immuno micro plates, inoculating loops and need… Read more